Risk factors for valproic acid resistance in childhood absence epilepsy

Area of Science:

• Pediatric Neurology
• Epilepsy Research
• Pharmacology

Background:

• Childhood absence epilepsy (CAE) is a common epilepsy syndrome.
• Valproic acid (VPA) is a first-line antiepileptic drug (AED) for CAE, with reported efficacy in up to 75% of children.
• Predictors of VPA response and long-term outcomes in newly diagnosed CAE are not fully understood.

Purpose of the Study:

• To identify clinical and socio-demographic factors associated with VPA response in newly diagnosed CAE.
• To determine if these factors influence long-term seizure freedom in children with CAE.

Main Methods:

• Retrospective review of medical charts of 180 children diagnosed with CAE.
• Correlation of clinical, electroencephalographic, and imaging findings with VPA response and epilepsy outcomes.
• Multivariable logistic regression analysis to identify factors associated with non-responsiveness.

Main Results:

• VPA treatment was successful in 58.3% of children.
• Non-responders were more likely to have experienced generalized tonic-clonic seizures (GTCS) and had higher pre-treatment seizure frequencies (>10/day).
• Responders were older at diagnosis; absence of long-term seizure freedom was linked to GTCS, lack of initial response, and need for multiple AEDs.

Conclusions:

• Clinical phenotypes, including GTCS and high seizure frequency, are associated with reduced VPA response rates in CAE.
• These findings are crucial for counseling families of children newly diagnosed with absence epilepsy regarding VPA treatment expectations.